Edwards announces milestones for transcatheter mitral program
Edwards Lifesciences announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. atients enrolled in the CLASP study had clinically significant mitral regurgitation (MR) despite optimal medical therapy. May 22, 2019